Yang Zi Wan Bao Wang·2025-05-15 08:16Group 1 - L'Oréal is reportedly interested in acquiring the UK skincare brand Medik8, which has sparked discussions in the industry [1] - Medik8 is known for its "CSA skincare philosophy" and has gained popularity for its "morning C, evening A" concept [2] - Medik8's sales are projected to grow by 50% in 2024, with global revenue expected to exceed $100 million (approximately 720 million RMB) in 2025 [4] Group 2 - L'Oréal's skincare division has been expanding rapidly, with sales surpassing 7 billion euros (approximately 54.8 billion RMB) in 2024, making it one of the fastest-growing segments of the company [6] - Estée Lauder's brand The Ordinary has entered the Chinese market, emphasizing high-concentration ingredient formulations at affordable prices [6] - Both L'Oréal and Estée Lauder are targeting a trend where consumers prefer effective and cost-efficient products [8] Group 3 - Local skincare brands like Winona and Yuze have established a strong market presence in China, leveraging a "medical-research co-creation" model [9] - The evolving consumer awareness in China indicates that mere ingredient stacking is insufficient; product texture, scientific formulation, and brand storytelling are becoming increasingly important [9] - For L'Oréal, building a distribution channel for Medik8 in China is crucial for market entry, while The Ordinary faces challenges from well-established local competitors [10]